Global Swine Live Vaccine Market Growth 2024-2030

December 2024 | 112 pages | ID: G3D783CAC3A9EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Swine Live Vaccine market size was valued at US$ million in 2023. With growing demand in downstream market, the Swine Live Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Swine Live Vaccine market. Swine Live Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Swine Live Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Swine Live Vaccine market.

Key Features:

The report on Swine Live Vaccine market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Swine Live Vaccine market. It may include historical data, market segmentation by Type (e.g., Porcine Reproductive and Respiratory Syndrome Vaccine, Swine Fever Vaccine), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Swine Live Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Swine Live Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Swine Live Vaccine industry. This include advancements in Swine Live Vaccine technology, Swine Live Vaccine new entrants, Swine Live Vaccine new investment, and other innovations that are shaping the future of Swine Live Vaccine.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Swine Live Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Swine Live Vaccine product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Swine Live Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Swine Live Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Swine Live Vaccine market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Swine Live Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Swine Live Vaccine market.

Market Segmentation:

Swine Live Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • Porcine Reproductive and Respiratory Syndrome Vaccine
  • Swine Fever Vaccine
  • Pseudorabies Vaccine
  • Others
Segmentation by application
  • Breeding Farm
  • Veterinary Clinic
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Boehringer Ingelheim
  • Harbin Pharmaceutical Group Bio-vaccine
  • DHN
  • Shenzhen BIOCBD Biotechnology
  • Jinyu Biotechnology
  • Zhongmu Industry
  • Qindao Lijian Bio-Tech
  • Wuhan Keqian Biology
  • Ceva Corporate
  • KM Biologics
  • Nisseiken
Key Questions Addressed in this Report

What is the 10-year outlook for the global Swine Live Vaccine market?

What factors are driving Swine Live Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Swine Live Vaccine market opportunities vary by end market size?

How does Swine Live Vaccine break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Swine Live Vaccine Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Swine Live Vaccine by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Swine Live Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Swine Live Vaccine Segment by Type
  2.2.1 Porcine Reproductive and Respiratory Syndrome Vaccine
  2.2.2 Swine Fever Vaccine
  2.2.3 Pseudorabies Vaccine
  2.2.4 Others
2.3 Swine Live Vaccine Sales by Type
  2.3.1 Global Swine Live Vaccine Sales Market Share by Type (2019-2024)
  2.3.2 Global Swine Live Vaccine Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Swine Live Vaccine Sale Price by Type (2019-2024)
2.4 Swine Live Vaccine Segment by Application
  2.4.1 Breeding Farm
  2.4.2 Veterinary Clinic
2.5 Swine Live Vaccine Sales by Application
  2.5.1 Global Swine Live Vaccine Sale Market Share by Application (2019-2024)
  2.5.2 Global Swine Live Vaccine Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Swine Live Vaccine Sale Price by Application (2019-2024)

3 GLOBAL SWINE LIVE VACCINE BY COMPANY

3.1 Global Swine Live Vaccine Breakdown Data by Company
  3.1.1 Global Swine Live Vaccine Annual Sales by Company (2019-2024)
  3.1.2 Global Swine Live Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Swine Live Vaccine Annual Revenue by Company (2019-2024)
  3.2.1 Global Swine Live Vaccine Revenue by Company (2019-2024)
  3.2.2 Global Swine Live Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Swine Live Vaccine Sale Price by Company
3.4 Key Manufacturers Swine Live Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Swine Live Vaccine Product Location Distribution
  3.4.2 Players Swine Live Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR SWINE LIVE VACCINE BY GEOGRAPHIC REGION

4.1 World Historic Swine Live Vaccine Market Size by Geographic Region (2019-2024)
  4.1.1 Global Swine Live Vaccine Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Swine Live Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Swine Live Vaccine Market Size by Country/Region (2019-2024)
  4.2.1 Global Swine Live Vaccine Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Swine Live Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Swine Live Vaccine Sales Growth
4.4 APAC Swine Live Vaccine Sales Growth
4.5 Europe Swine Live Vaccine Sales Growth
4.6 Middle East & Africa Swine Live Vaccine Sales Growth

5 AMERICAS

5.1 Americas Swine Live Vaccine Sales by Country
  5.1.1 Americas Swine Live Vaccine Sales by Country (2019-2024)
  5.1.2 Americas Swine Live Vaccine Revenue by Country (2019-2024)
5.2 Americas Swine Live Vaccine Sales by Type
5.3 Americas Swine Live Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Swine Live Vaccine Sales by Region
  6.1.1 APAC Swine Live Vaccine Sales by Region (2019-2024)
  6.1.2 APAC Swine Live Vaccine Revenue by Region (2019-2024)
6.2 APAC Swine Live Vaccine Sales by Type
6.3 APAC Swine Live Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Swine Live Vaccine by Country
  7.1.1 Europe Swine Live Vaccine Sales by Country (2019-2024)
  7.1.2 Europe Swine Live Vaccine Revenue by Country (2019-2024)
7.2 Europe Swine Live Vaccine Sales by Type
7.3 Europe Swine Live Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Swine Live Vaccine by Country
  8.1.1 Middle East & Africa Swine Live Vaccine Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Swine Live Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Swine Live Vaccine Sales by Type
8.3 Middle East & Africa Swine Live Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Swine Live Vaccine
10.3 Manufacturing Process Analysis of Swine Live Vaccine
10.4 Industry Chain Structure of Swine Live Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Swine Live Vaccine Distributors
11.3 Swine Live Vaccine Customer

12 WORLD FORECAST REVIEW FOR SWINE LIVE VACCINE BY GEOGRAPHIC REGION

12.1 Global Swine Live Vaccine Market Size Forecast by Region
  12.1.1 Global Swine Live Vaccine Forecast by Region (2025-2030)
  12.1.2 Global Swine Live Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Swine Live Vaccine Forecast by Type
12.7 Global Swine Live Vaccine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Boehringer Ingelheim
  13.1.1 Boehringer Ingelheim Company Information
  13.1.2 Boehringer Ingelheim Swine Live Vaccine Product Portfolios and Specifications
  13.1.3 Boehringer Ingelheim Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 Boehringer Ingelheim Main Business Overview
  13.1.5 Boehringer Ingelheim Latest Developments
13.2 Harbin Pharmaceutical Group Bio-vaccine
  13.2.1 Harbin Pharmaceutical Group Bio-vaccine Company Information
  13.2.2 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolios and Specifications
  13.2.3 Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 Harbin Pharmaceutical Group Bio-vaccine Main Business Overview
  13.2.5 Harbin Pharmaceutical Group Bio-vaccine Latest Developments
13.3 DHN
  13.3.1 DHN Company Information
  13.3.2 DHN Swine Live Vaccine Product Portfolios and Specifications
  13.3.3 DHN Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 DHN Main Business Overview
  13.3.5 DHN Latest Developments
13.4 Shenzhen BIOCBD Biotechnology
  13.4.1 Shenzhen BIOCBD Biotechnology Company Information
  13.4.2 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolios and Specifications
  13.4.3 Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Shenzhen BIOCBD Biotechnology Main Business Overview
  13.4.5 Shenzhen BIOCBD Biotechnology Latest Developments
13.5 Jinyu Biotechnology
  13.5.1 Jinyu Biotechnology Company Information
  13.5.2 Jinyu Biotechnology Swine Live Vaccine Product Portfolios and Specifications
  13.5.3 Jinyu Biotechnology Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Jinyu Biotechnology Main Business Overview
  13.5.5 Jinyu Biotechnology Latest Developments
13.6 Zhongmu Industry
  13.6.1 Zhongmu Industry Company Information
  13.6.2 Zhongmu Industry Swine Live Vaccine Product Portfolios and Specifications
  13.6.3 Zhongmu Industry Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Zhongmu Industry Main Business Overview
  13.6.5 Zhongmu Industry Latest Developments
13.7 Qindao Lijian Bio-Tech
  13.7.1 Qindao Lijian Bio-Tech Company Information
  13.7.2 Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolios and Specifications
  13.7.3 Qindao Lijian Bio-Tech Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Qindao Lijian Bio-Tech Main Business Overview
  13.7.5 Qindao Lijian Bio-Tech Latest Developments
13.8 Wuhan Keqian Biology
  13.8.1 Wuhan Keqian Biology Company Information
  13.8.2 Wuhan Keqian Biology Swine Live Vaccine Product Portfolios and Specifications
  13.8.3 Wuhan Keqian Biology Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 Wuhan Keqian Biology Main Business Overview
  13.8.5 Wuhan Keqian Biology Latest Developments
13.9 Ceva Corporate
  13.9.1 Ceva Corporate Company Information
  13.9.2 Ceva Corporate Swine Live Vaccine Product Portfolios and Specifications
  13.9.3 Ceva Corporate Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 Ceva Corporate Main Business Overview
  13.9.5 Ceva Corporate Latest Developments
13.10 KM Biologics
  13.10.1 KM Biologics Company Information
  13.10.2 KM Biologics Swine Live Vaccine Product Portfolios and Specifications
  13.10.3 KM Biologics Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 KM Biologics Main Business Overview
  13.10.5 KM Biologics Latest Developments
13.11 Nisseiken
  13.11.1 Nisseiken Company Information
  13.11.2 Nisseiken Swine Live Vaccine Product Portfolios and Specifications
  13.11.3 Nisseiken Swine Live Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Nisseiken Main Business Overview
  13.11.5 Nisseiken Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES
.
Table 1. Swine Live Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Swine Live Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Porcine Reproductive and Respiratory Syndrome Vaccine
Table 4. Major Players of Swine Fever Vaccine
Table 5. Major Players of Pseudorabies Vaccine
Table 6. Major Players of Others
Table 7. Global Swine Live Vaccine Sales by Type (2019-2024) & (K Units)
Table 8. Global Swine Live Vaccine Sales Market Share by Type (2019-2024)
Table 9. Global Swine Live Vaccine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Swine Live Vaccine Revenue Market Share by Type (2019-2024)
Table 11. Global Swine Live Vaccine Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Swine Live Vaccine Sales by Application (2019-2024) & (K Units)
Table 13. Global Swine Live Vaccine Sales Market Share by Application (2019-2024)
Table 14. Global Swine Live Vaccine Revenue by Application (2019-2024)
Table 15. Global Swine Live Vaccine Revenue Market Share by Application (2019-2024)
Table 16. Global Swine Live Vaccine Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Swine Live Vaccine Sales by Company (2019-2024) & (K Units)
Table 18. Global Swine Live Vaccine Sales Market Share by Company (2019-2024)
Table 19. Global Swine Live Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Swine Live Vaccine Revenue Market Share by Company (2019-2024)
Table 21. Global Swine Live Vaccine Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Swine Live Vaccine Producing Area Distribution and Sales Area
Table 23. Players Swine Live Vaccine Products Offered
Table 24. Swine Live Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Swine Live Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Swine Live Vaccine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Swine Live Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Swine Live Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Swine Live Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Swine Live Vaccine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Swine Live Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Swine Live Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Swine Live Vaccine Sales by Country (2019-2024) & (K Units)
Table 36. Americas Swine Live Vaccine Sales Market Share by Country (2019-2024)
Table 37. Americas Swine Live Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Swine Live Vaccine Revenue Market Share by Country (2019-2024)
Table 39. Americas Swine Live Vaccine Sales by Type (2019-2024) & (K Units)
Table 40. Americas Swine Live Vaccine Sales by Application (2019-2024) & (K Units)
Table 41. APAC Swine Live Vaccine Sales by Region (2019-2024) & (K Units)
Table 42. APAC Swine Live Vaccine Sales Market Share by Region (2019-2024)
Table 43. APAC Swine Live Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Swine Live Vaccine Revenue Market Share by Region (2019-2024)
Table 45. APAC Swine Live Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. APAC Swine Live Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Europe Swine Live Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Europe Swine Live Vaccine Sales Market Share by Country (2019-2024)
Table 49. Europe Swine Live Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Swine Live Vaccine Revenue Market Share by Country (2019-2024)
Table 51. Europe Swine Live Vaccine Sales by Type (2019-2024) & (K Units)
Table 52. Europe Swine Live Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Swine Live Vaccine Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Swine Live Vaccine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Swine Live Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Swine Live Vaccine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Swine Live Vaccine Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Swine Live Vaccine Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Swine Live Vaccine
Table 60. Key Market Challenges & Risks of Swine Live Vaccine
Table 61. Key Industry Trends of Swine Live Vaccine
Table 62. Swine Live Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Swine Live Vaccine Distributors List
Table 65. Swine Live Vaccine Customer List
Table 66. Global Swine Live Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Swine Live Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Swine Live Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Swine Live Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Swine Live Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Swine Live Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Swine Live Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Swine Live Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Swine Live Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Swine Live Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Swine Live Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Swine Live Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Swine Live Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Swine Live Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Boehringer Ingelheim Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Boehringer Ingelheim Swine Live Vaccine Product Portfolios and Specifications
Table 82. Boehringer Ingelheim Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Main Business
Table 84. Boehringer Ingelheim Latest Developments
Table 85. Harbin Pharmaceutical Group Bio-vaccine Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Product Portfolios and Specifications
Table 87. Harbin Pharmaceutical Group Bio-vaccine Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Harbin Pharmaceutical Group Bio-vaccine Main Business
Table 89. Harbin Pharmaceutical Group Bio-vaccine Latest Developments
Table 90. DHN Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. DHN Swine Live Vaccine Product Portfolios and Specifications
Table 92. DHN Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. DHN Main Business
Table 94. DHN Latest Developments
Table 95. Shenzhen BIOCBD Biotechnology Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Product Portfolios and Specifications
Table 97. Shenzhen BIOCBD Biotechnology Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Shenzhen BIOCBD Biotechnology Main Business
Table 99. Shenzhen BIOCBD Biotechnology Latest Developments
Table 100. Jinyu Biotechnology Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Jinyu Biotechnology Swine Live Vaccine Product Portfolios and Specifications
Table 102. Jinyu Biotechnology Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Jinyu Biotechnology Main Business
Table 104. Jinyu Biotechnology Latest Developments
Table 105. Zhongmu Industry Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Zhongmu Industry Swine Live Vaccine Product Portfolios and Specifications
Table 107. Zhongmu Industry Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Zhongmu Industry Main Business
Table 109. Zhongmu Industry Latest Developments
Table 110. Qindao Lijian Bio-Tech Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Qindao Lijian Bio-Tech Swine Live Vaccine Product Portfolios and Specifications
Table 112. Qindao Lijian Bio-Tech Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Qindao Lijian Bio-Tech Main Business
Table 114. Qindao Lijian Bio-Tech Latest Developments
Table 115. Wuhan Keqian Biology Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Wuhan Keqian Biology Swine Live Vaccine Product Portfolios and Specifications
Table 117. Wuhan Keqian Biology Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Wuhan Keqian Biology Main Business
Table 119. Wuhan Keqian Biology Latest Developments
Table 120. Ceva Corporate Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Ceva Corporate Swine Live Vaccine Product Portfolios and Specifications
Table 122. Ceva Corporate Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Ceva Corporate Main Business
Table 124. Ceva Corporate Latest Developments
Table 125. KM Biologics Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. KM Biologics Swine Live Vaccine Product Portfolios and Specifications
Table 127. KM Biologics Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. KM Biologics Main Business
Table 129. KM Biologics Latest Developments
Table 130. Nisseiken Basic Information, Swine Live Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Nisseiken Swine Live Vaccine Product Portfolios and Specifications
Table 132. Nisseiken Swine Live Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Nisseiken Main Business
Table 134. Nisseiken Latest Developments

LIST OF FIGURES
.
Figure 1. Picture of Swine Live Vaccine
Figure 2. Swine Live Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Swine Live Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Swine Live Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Swine Live Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Porcine Reproductive and Respiratory Syndrome Vaccine
Figure 10. Product Picture of Swine Fever Vaccine
Figure 11. Product Picture of Pseudorabies Vaccine
Figure 12. Product Picture of Others
Figure 13. Global Swine Live Vaccine Sales Market Share by Type in 2023
Figure 14. Global Swine Live Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Swine Live Vaccine Consumed in Breeding Farm
Figure 16. Global Swine Live Vaccine Market: Breeding Farm (2019-2024) & (K Units)
Figure 17. Swine Live Vaccine Consumed in Veterinary Clinic
Figure 18. Global Swine Live Vaccine Market: Veterinary Clinic (2019-2024) & (K Units)
Figure 19. Global Swine Live Vaccine Sales Market Share by Application (2023)
Figure 20. Global Swine Live Vaccine Revenue Market Share by Application in 2023
Figure 21. Swine Live Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Swine Live Vaccine Sales Market Share by Company in 2023
Figure 23. Swine Live Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Swine Live Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Swine Live Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Swine Live Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Swine Live Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Swine Live Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Swine Live Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Swine Live Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Swine Live Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Swine Live Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Swine Live Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Swine Live Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Swine Live Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Swine Live Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Swine Live Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Swine Live Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Swine Live Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Swine Live Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Swine Live Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Swine Live Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Swine Live Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Swine Live Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Swine Live Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Swine Live Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Swine Live Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Swine Live Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Swine Live Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Swine Live Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Swine Live Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Swine Live Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Swine Live Vaccine
Figure 74. Industry Chain Structure of Swine Live Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Swine Live Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Swine Live Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Swine Live Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Swine Live Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Swine Live Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Swine Live Vaccine Revenue Market Share Forecast by Application (2025-2030)


More Publications